Sep 23, 2024 2024 ABPI Code of Practice launched - orange is the new blue By Jamie Hatzel The ABPI and the Prescription Medicines Code of Practice Authority (PMCPA) have announced the release of the latest edition of the ABPI...
Aug 19, 2024 CASGEVY: CRISPR/Cas9 gene therapy now available in England following NICE recommendation By Claire Smith Luca Cericola Vertex Pharmaceuticals announced a reimbursement agreement with NHS England for individuals 12 years or older with transfusion-dependent...
Jul 10, 2024 Challenges and opportunities for bio innovation: Views from the ON Helix 2024 conference By Adam Coughlin Luca Cericola Last week, Adam Coughlin and Luca Cericola from Bristows’ Commercial IP team attended ON Helix 2024, an annual conference hosted by One...
Jun 25, 2024 Biotech Review of the Year: Six months on By Bristows LLP It's hard to believe that six months have passed since we released the 11th edition of our Biotech Review of the Year publication. Our...
Jun 13, 2024 Takeaways from the EU Pharma Law Forum 2024 By Jamie Hatzel Bristows was delighted to sponsor and attend this year’s EU Pharmaceutical Law Forum, which was held in Brussels at the Steigenberger...
Jun 11, 2024 Deal-making for cell and gene therapy companies: Insights from One Nucleus’ panel event By Claire Smith Luca Cericola Cell and gene therapies (CGTs) continue to hold considerable promise for the future of medicine, providing unprecedented therapeutic...
Mar 28, 2024 Publication - Patents: Review of the Year By Dominic Adair Katie Cambrook Brian Cordery Chloe Dickson Charlie French Matthew Hunt Nicholas Round Jonathan Ross Eden Winlow +6 more... Show less For patent practitioners everywhere, 2023 was a significant year. Ten years after the signing of the international treaty governing its...
Mar 25, 2024 A detailed analysis of the first substantive UPC Court of Appeal decision – lifting a preliminary injunction against NanoString By Eden Winlow NanoString Technologies Inc.; NanoString Technologies Germany GmbH; NanoString Technologies Netherlands B.V. v President and Fellows of...
Mar 01, 2024 MHRA grants first medicine approval via the new International Recognition Procedure By Jamie Hatzel For the very first time, the MHRA has a granted a UK marketing authorisation (UKMA) for a medicine through its new International...
Jan 18, 2024 Publication: Biotech Review of the Year By Gregory Bacon Xisca Borrás Will Hewitt 2023 is likely to be remembered as a year in which a number of highly anticipated developments in the biotech industry finally came to...
Sep 25, 2023 MHRA simplifies legal representative requirements for clinical investigations in Northern Ireland By Jamie Hatzel Since Brexit, the UK has been subject to two separate regulatory frameworks on medical devices. Great Britain is subject to the Medical...
Aug 31, 2023 A Turing Test for Embryos? By Bristows Philip Ball writes on an important contribution to the discussion on the twilit zone between human embryo models and actual human...